More on Semaglutide in Early Type 1 Diabetes
N Engl J Med
.
2024 Jan 18;390(3):290.
doi: 10.1056/NEJMc2311608.
Author
J Hans DeVries
1
Affiliation
1
Amsterdam University Medical Centers, Amsterdam, the Netherlands j.h.devries@amc.uva.nl.
PMID:
38231640
DOI:
10.1056/NEJMc2311608
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetes Mellitus, Type 1* / drug therapy
Glucagon-Like Peptides / therapeutic use
Humans
Hypoglycemic Agents / therapeutic use
Substances
semaglutide
Glucagon-Like Peptides
Hypoglycemic Agents